FDA And Pfizer Need A Covid-19 Reality Booster

Yesterday’s FDA Vaccines and Related Biological Products (VRBPAC) meeting on the Pfizer booster was so problematic as to make a reasonable person wonder whether our vaccine strategy was ever about science.

Read the full post on Forbes - Healthcare